Vanguard realignment: Progyny (PGNY) Schedule 13G/A shows 0 shares
Rhea-AI Filing Summary
Progyny Inc disclosure: The Vanguard Group filed Amendment No. 5 to a Schedule 13G/A reporting 0 shares beneficially owned, representing 0% of Progyny's common stock. The filing explains an internal realignment effective January 12, 2026, causing certain Vanguard subsidiaries to report holdings separately.
Positive
- None.
Negative
- None.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What did The Vanguard Group report for PGNY in Amendment No. 5?
Answer: The Vanguard Group reported 0 shares beneficially owned, equal to 0% of common stock. The filing states Vanguard underwent an internal realignment on January 12, 2026, leading subsidiaries to report separately.
Why does the Schedule 13G/A show zero ownership for Vanguard?
Answer: The amendment explains an internal realignment where certain Vanguard subsidiaries now report beneficial ownership separately in reliance on SEC Release No. 34-39538, and Vanguard no longer is deemed to beneficially own those subsidiary-held securities.
Who signed the filing on behalf of The Vanguard Group for PGNY?
Answer: The filing is signed by Ashley Grim, Head of Global Fund Administration, with the signature date shown as 03/27/2026, attesting to the Schedule 13G/A amendment details.
Does the amendment identify any other persons holding more than 5% of PGNY?
Answer: The filing states that no other person's interest in the securities reported is more than 5%. It lists Vanguard-managed accounts but confirms no single outside person exceeds the 5% threshold.